Trial Profile
Effect of gaboxadol and zolpidem on cyclic alternating pattern.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Mar 2011
Price :
$35
*
At a glance
- Drugs Gaboxadol - Ovid Therapeuticsgaboxadol (Primary) ; Zolpidem
- Indications Insomnia
- Focus Pharmacodynamics
- Sponsors Lundbeck A/S; Merck & Co
- 18 Mar 2011 New trial record